AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Gynecologic Oncology Group to conduct phase III trial of Xyotax.(ovarian cancer treatment)
2002 DEC 12 - (NewsRx.com & NewsRx.net) -- Cell Therapeutics, Inc., (CTI) (CTIC) and the Gynecologic Oncology Group (GOG) announced that the GOG will conduct a phase III trial of Xyotax in front-line treatment of ovarian cancer.
The trial is expected to begin in 2003 and to enroll approximately 1,000 patients over 12 months.
"The mission of the GOG is to improve the lives and outcomes of patients with gynecologic cancers. While we have made significant progress in prolonging the lives of women with ovarian cancer, one of our biggest challenges is to improve their quality of life, given the serious side effects of current chemotherapy," noted Larry J. Copeland, MD, Department of Obstetrics and Gynecology Chair, James Cancer Hospital, Ohio State University and Ovarian Protocol Committee chair and vice chair of the GOG.
"A new tumor-targeted agent, like Xyotax, that is easier to administer to patients and accompanied by the potential for them to experience fewer of the severe, often debilitating, side effects of current taxane therapy could represent a significant advance in the treatment of this disease. We have been impressed with the quality of the science at CTI and their commitment to making cancer more treatable and are excited about the prospects of this relationship for our patients."
According to the National Cancer Institute, about one in ...
- Gemzar Combination Demonstrates Significant Advance Compared to a Standard of...
- Press release article from: PR Newswire June 6, 2004 700+ words
...recurrent epithelial ovarian cancer patients over carboplatin...advance for women whose ovarian cancer recurs more than six...based treatment. "Ovarian cancer claims more lives in...from the randomized Phase III study showed median...
- R1549 does not meet primary endpoint in Phase III study in ovarian cancer.
- News wire article from: Asia Africa Intelligence Wire April 26, 2004 700+ words
...RadioimmunoTherapy), a Phase III study of R1549 in ovarian cancer. The outcomes for R1549...future research into ovarian cancer. SMART is a Phase III randomised, single...than 420 women with ovarian cancer in seventeen countries...
- Abbott Laboratories Urges Ovarian Cancer Patients to Participate in a Phase III...
- Press release article from: PR Newswire May 9, 2000 700+ words
...Recently diagnosed ovarian cancer patients are needed...the country for a phase III clinical trial of...adjuvant treatment of ovarian cancer. "A new treatment...women who suffer from ovarian cancer, a disease with only...
- BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer...
- Press release article from: PR Newswire February 7, 2008 700+ words
...patient in a global Phase III clinical trial...R) in advanced ovarian cancer patients. BioNumerik...Phase II advanced ovarian cancer trial compare favorably...pursuing Karenitecin Phase III testing in advanced ovarian cancer patients who have...
- Gynecologic Oncology Group to Conduct Front-Line Phase III Trial of XYOTAX(TM)...
- Press release article from: PR Newswire November 5, 2002 700+ words
...GOG will conduct a phase III trial of XYOTAX in front-line treatment of ovarian cancer. The trial is expected...conducting high quality phase III trials upon which...organization lead our phase III ovarian cancer trial. This not only...
- First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial.
- Press release article from: PR Newswire August 27, 2007 700+ words
...Europe in the Phase III Ovature clinical...with advanced ovarian cancer resistant or...takes for the ovarian cancer to progress...Naughton, said the Phase III Ovature study...with late stage ovarian cancer that had become...
- Telik announces initiation of New Telcyta Phase III clinical trial and updates...
- News wire article from: Chemical Business Newsbase May 2, 2006 700+ words
...international Phase III clinical trial...or resistant ovarian cancer. Telik plans...or resistant ovarian cancer. If the trial...two additional Phase III trials ongoing...or resistant ovarian cancer, ASSIST-1...
- First Patient Treated in Phase III Ovarian Cancer Trial.
- Press release article from: PR Newswire November 27, 2006 700+ words
...treatment in the Phase III "OVATURE" clinical...multi-national ovarian cancer study to confirm...chemosensitizing effect on ovarian cancer when chemotherapy...with late stage ovarian cancer whose tumors...Naughton, said the Phase III Ovature study...
- R1549 fails to meet primary endpoint in phase III ovarian cancer study.
- Newspaper article from: Health & Medicine Week May 24, 2004 700+ words
...RadioimmunoTherapy), a phase III study of R1549 in ovarian cancer, and that the outcomes...highly significant phase III data on Tarceva...RadioimmunoTherapy) is a phase III randomized, single...than 420 women with ovarian cancer in 17 countries...
- Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special...
- Press release article from: PR Newswire March 23, 2009 700+ words
...single, pivotal, Phase III clinical trial...platinum-sensitive ovarian cancer patients experiencing...protocol for this Phase III study of farletuzumab...platinum-sensitive ovarian cancer," stated Martin...benefit patients with ovarian cancer in a ...
Source: HighBeam Research, Gynecologic Oncology Group to conduct phase III trial of...